AstraZeneca PLC (AZN)
166.80
+0.82
(+0.49%)
USD |
NYSE |
Aug 24, 16:00
166.71
-0.09
(-0.05%)
After-Hours: 20:00
AstraZeneca Total Liabilities (Quarterly) : 66.63B for March 31, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2026 | 66.63B |
| December 31, 2025 | 65.30B |
| September 30, 2025 | 68.48B |
| June 30, 2025 | 67.61B |
| March 31, 2025 | 65.12B |
| December 31, 2024 | 63.16B |
| September 30, 2024 | 64.12B |
| June 30, 2024 | 64.74B |
| March 31, 2024 | 64.79B |
| December 31, 2023 | 61.95B |
| September 30, 2023 | 58.86B |
| June 30, 2023 | 59.13B |
| March 31, 2023 | 60.88B |
| December 31, 2022 | 59.42B |
| September 30, 2022 | 59.03B |
| June 30, 2022 | 60.63B |
| March 31, 2022 | 63.91B |
| December 31, 2021 | 66.08B |
| September 30, 2021 | 67.31B |
| June 30, 2021 | 57.95B |
| March 31, 2021 | 50.48B |
| December 31, 2020 | 51.09B |
| September 30, 2020 | 50.49B |
| June 30, 2020 | 46.27B |
| March 31, 2020 | 45.00B |
| Date | Value |
|---|---|
| December 31, 2019 | 46.78B |
| September 30, 2019 | 45.24B |
| June 30, 2019 | 46.82B |
| March 31, 2019 | 49.03B |
| December 31, 2018 | 46.61B |
| September 30, 2018 | 47.91B |
| June 30, 2018 | 47.07B |
| March 31, 2018 | 48.71B |
| December 31, 2017 | 46.71B |
| September 30, 2017 | 49.14B |
| June 30, 2017 | 49.71B |
| March 31, 2017 | 46.18B |
| December 31, 2016 | 45.86B |
| September 30, 2016 | 48.26B |
| June 30, 2016 | 48.98B |
| March 31, 2016 | 47.56B |
| December 31, 2015 | 41.62B |
| September 30, 2015 | 36.75B |
| June 30, 2015 | 36.87B |
| March 31, 2015 | 36.74B |
| December 31, 2014 | 38.95B |
| September 30, 2014 | 35.70B |
| June 30, 2014 | 36.49B |
| March 31, 2014 | 37.91B |
| December 31, 2013 | 32.65B |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| GSK Plc | 59.14B |
| Johnson & Johnson | 116.09B |
| Eli Lilly & Co. | 108.40B |
| Merck & Co., Inc. | 87.82B |
| Novo Nordisk A/S | 57.15B |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 114.02B |
| Shareholders Equity (Quarterly) | 47.33B |
| Debt to Equity Ratio | 0.7166 |
| Current Ratio | 0.9092 |
| Net Debt Paydown Yield | -0.12% |